Converting Cold into Hot Tumors by Combining Immunotherapies
- PMID: 28886376
- DOI: 10.1016/j.cell.2017.08.031
Converting Cold into Hot Tumors by Combining Immunotherapies
Abstract
In a small phase Ib study in this issue of Cell, Ribas et al. report that the combination of intralesional injection of a modified human herpes simplex virus and systemic anti-PD-1 treatment resulted in a 62% response rate in patients with metastatic melanoma, accompanied by enhanced T cell infiltration in virus-injected lesions.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.Cell. 2017 Sep 7;170(6):1109-1119.e10. doi: 10.1016/j.cell.2017.08.027. Cell. 2017. PMID: 28886381 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
